Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
332 hedge funds and large institutions have $5.35B invested in Amedisys in 2020 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 96 increasing their positions, 136 reducing their positions, and 42 closing their positions.
24% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 42
10% more capital invested
Capital invested by funds: $4.85B → $5.35B (+$503M)
2% more funds holding
Funds holding: 325 → 332 (+7)
0.27% more ownership
Funds ownership: 89.97% → 90.24% (+0.27%)
29% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 136
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
43% less call options, than puts
Call options by funds: $34.9M | Put options by funds: $61M
Top Buyers
| 1 |
Ninety One (UK)
London,
United Kingdom
|
+$55.4M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$36.2M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$26.1M |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$20.4M |
| 5 |
BlackRock
New York
|
+$20.3M |
Top Sellers
AMED Hedge Fund Activity: Q1 2020 in Review
332 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2020, worth a combined $5.35B — up 10% from $4.85B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new AMED positions and 42 closed out — a net gain of 10 holders — while 96 added to existing stakes and 136 trimmed.
The largest buyer was Ninety One (UK), opening a new position worth an estimated $55.4M. The largest seller was VOYA Investment Management, cutting an estimated $35.8M.
- 332 institutional investors held Amedisys (AMED) as of Q1 2020, up from 325 in Q4 2019.
- Funds reported $5.35B of Amedisys stock for Q1 2020, up 10% quarter-over-quarter.
- 52 funds opened new Amedisys positions in Q1 2020 and 42 closed out, a net change of +10 holders.
- The largest Amedisys buyer in Q1 2020 was Ninety One (UK), an estimated $55.4M added.
- The largest Amedisys seller in Q1 2020 was VOYA Investment Management, an estimated $35.8M sold.
Based on aggregated 13F filings for Q1 2020.